Drug Shortage Report for CILOXAN

Last updated on 2022-10-07 History
Report ID 169228
Drug Identification Number 01945270
Brand name CILOXAN
Common or Proper name CILOXAN 0.3% SOLUTION
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status MARKETED
Active Ingredient(s) CIPROFLOXACIN
Strength(s) 0.3%
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 5ML
ATC code S03AA
ATC description ANTIINFECTIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2022-09-14
Actual start date 2022-09-14
Estimated end date Unknown
Actual end date 2022-10-06
Shortage status Resolved
Updated date 2022-10-07
Company comments Release of Lot# 117A9 on Oct 6th
Health Canada comments
Tier 3 Status No
Contact Address 385 BOUCHARD BLVD
DORVAL, QUEBEC
CANADA H9S 1A9
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2022-10-07 French Compare
v4 2022-10-07 English Compare
v3 2022-09-15 English Compare
v2 2022-09-14 French Compare
v1 2022-09-14 English Compare

Showing 1 to 5 of 5